The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women

Infectious Diseases in Obstetrics and Gynecology

Volumn 2008, Issue , 2008, Pages

  Minkoff, Howard ^a   Zhong, Ye ^b   Strickler, Howard D ^b   Watts, D Heather ^c   Palefsky, Joel M ^d   Levine, Alexandra M ^e   D'Souza, Gypsyamber ^f   Howard, Andrea A ^g   Plankey, Michael ^h   Massad, L Stewart ⁱ   Burk, Robert ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g Columbia University ^*  (United States)

^h GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ARTICLE; CANCER INCIDENCE; CD4+ T LYMPHOCYTE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; SEXUALITY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; ADULT; CLINICAL TRIAL; COCAINE DEPENDENCE; HIGH RISK BEHAVIOR; IMMUNE DEFICIENCY; IMMUNOLOGY; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; UTERINE CERVIX DISEASE; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COCAINE; COCAINE-RELATED DISORDERS; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; RISK-TAKING; SEXUAL PARTNERS; SMOKING; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 43549098243     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2008/587082     Document Type: Article

References (34)

1. Palefsky J. M., Minkoff H., Kalish L. A., Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women Journal of the National Cancer Institute 1999 91 3 226 236
2. Minkoff H., Feldman J., DeHovitz J., Landesman S., Burk R., A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women American Journal of Obstetrics and Gynecology 1998 178 5 982 986
3. Minkoff H., Matityahu D., Feldman J., Burk R., Clake L., Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus American Journal of Obstetrics and Gynecology 1999 180 4 824 836
4. Strickler H. D., Burk R., Fazzari M., Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women Journal of the National Cancer Institute 2005 97 8 577 586
5. Ellerbrock T. V., Chiasson M. A., Bush T. J., Incidence of cervical squamous intraepithelial lesions in HIV-infected women The Journal of the American Medical Association 2000 283 8 1031 1037
6. Ahdieh L., Klein R. S., Burk R., Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women The Journal of Infectious Diseases 2001 184 6 682 690
7. Gallagher B., Wang Z., Schymura M. J., Kahn A., Fordyce E. J., Cancer incidence in New York State acquired immunodeficiency syndrome patients American Journal of Epidemiology 2001 154 6 544 556
8. Didelot-Rousseau M.-N., Nagot N., Costes-Martineau V., Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso British Journal of Cancer 2006 95 3 355 362
9. McQuillan G. M., Kruszon-Moran D., Kottiri B. J., Prevalence of HIV in the US household population: the national health and nutrition examination surveys, 1988 to 2002 Journal of Acquired Immune Deficiency Syndromes 2006 41 5 651 656
10. Minkoff H., McCalla S., Delke I., Stevens R., Salwen M., Feldman J., The relationship of cocaine use to syphilis and human immunodeficiency virus infections among inner city parturient women American Journal of Obstetrics and Gynecology 1990 163 2 521 526
11. Shen M.-L., Luo Y. D., Hagen K., Wu Y. B., Ou D., Immunomodulating activities of cocaine - evaluation of lymphocyte transformation related to other immune functions International Journal of Immunopharmacology 1994 16 4 311 319
12. Starec M., Rouveix B., Sinet M., Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus The Journal of Pharmacology and Experimental Therapeutics 1991 259 2 745 750
13. Avila A. H., Morgan C. A., Bayer B. M., Stress-induced suppression of the immune system after withdrawal from chronic cocaine Journal of Pharmacology and Experimental Therapeutics 2003 305 1 290 297
14. Ruiz P., Cleary T., Nassiri M., Steele B., Human T lymphocyte subpopulation and NK cell alterations in persons exposed to cocaine Clinical Immunology and Immunopathology 1994 70 3 245 250
15. Baldwin G. C., Roth M. D., Tashkin D. P., Acute and chronic effects of cocaine on the immune system and the possible link to AIDS Journal of Neuroimmunology 1998 83 1-2 133 138
16. Irwin M. R., Olmos L., Wang M., Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: autonomic mechanisms Journal of Pharmacology and Experimental Therapeutics 2007 320 2 507 515
17. Gekker G., Hu S., Sheng W. S., Rock R. B., Lokensgard J. R., Peterson P. K., Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor- β 1 International Immunopharmacology 2006 6 6 1029 1033
18. Clifford G. M., Polesel J., Rickenbach M., Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy Journal of the National Cancer Institute 2005 97 6 425 432
19. Barkan S. E., Melnick S. L., Preston-Martin S., The women's interagency HIV study (WIHS)-design, methods, sample, cohort characteristics and comparison with reported AIDS cases in US women Epidemiology 1998 9 117 125
20. Palefsky J. M., Minkoff H., Kalish L. A., Cervicovaginal human papilloma virus infection in HIV-positive and high risk HIV-negative women Journal of the National Cancer Institute 1999 91 3 226 236
21. Tachezy R., Vanranst M. A., Cruz Y., Burk R., Analysis of short novel human papillomavirus sequences Biochemical and Biophysical Research Communications 1994 204 2 820 827
22. Hildesheim A., Schiffman M. H., Gravitt P. E., Persistence of type-specific human papillomavirus infection among cytologically normal women Journal of Infectious Diseases 1994 169 2 235 240
23. Burk R., Ho G. Y., Beardsley L., Lempa M., Peters M., Bierman R., Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women Journal of Infectious Diseases 1996 174 4 679 689
24. Muñoz N., Bosch F. X., de Sanjosé S., Epidemiologic classification of human papillomavirus types associated with cervical cancer The New England Journal of Medicine 2003 348 6 518 527
25. Kurman R. J., Solomon D., The Bethesda System for Reporting Cervical/Vaginal Diagnoses 1994 New York, NY, USA Springer
26. Revets H., Marissens D., de Wit S., Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma Journal of Clinical Microbiology 1996 34 5 1058 1064
27. Strickler H. D., Palefsky J. M., Shah K. V., Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women Journal of National Cancer Institute 2003 95 14 1062 1071
28. Zeger S. L., Liang K. Y., Albert P. S., Models for longitudinal data: a generalized estimating equation approach Biometrics 1988 44 4 1049 1060
29. Cox D. R., Regression models and life-tables Journal of the Royal Statistical Society B 1972 34 2 187 220
30. Wei L. J., Lin D. Y., Weissfeld L., Regression analysis of multivariate incomplete failure time data by modelling marginal distributions Journal of the American Statistical Association 1989 84 1065 1073
31. Minkoff H., Feldman J. G., Strickler H. D., Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women The Journal of Infectious Diseases 2004 189 10 1821 1828
32. Bierl C., Karem K., Poon A. C., Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study Gynecologic Oncology 2005 99 3, supplement 1 S262 S268
33. Lopez M. C., Watson R. R., Effect of cocaine and murine AIDS on lamina propria T and B cells in normal mice Life Sciences 1994 54 9 PL147 PL151
34. Minkoff H., Ahdieh L., Massad L. S., The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women AIDS 2001 15 16 2157 2164